Literature DB >> 33295137

Maxillary sinus augmentation with three different biomaterials: Histological, histomorphometric, clinical, and patient-reported outcomes from a randomized controlled trial.

Eugenio Velasco-Ortega1, Nicola Alberto Valente1,2, Giovanna Iezzi3, Morena Petrini3, Giacomo Derchi4, Antonio Barone2,4.   

Abstract

BACKGROUND: Lateral maxillary sinus augmentation (MSA) is a predictable bone regeneration technique in case of atrophy of the posterior-upper maxilla. Aimed at obtaining quantity and quality of bone suitable for receiving osseointegrated implants, its success is largely due to the skill of the surgeon, but also to the characteristics of the biomaterial used.
METHODS: Twenty-four patients needing MSA were included in the study. The patients were randomly allocated to three different groups: anorganic bovine bone mineral as control, tricalcium phosphate with or without hyaluronic acid (HA) as test groups. Nine months after MSA, bone biopsies were harvested for the histomorphometric analysis. Secondary outcomes were mean bone gain, intraoperative and postoperative complications, implant insertion torque, implant failure, and patient-reported outcome measures.
RESULTS: Although the percentage of new bone was not statistically different between the three groups (P = .191), the percentages of residual biomaterial was significantly higher (P < .000) and nonmineralized tissue significantly lower (P < .000) in the control than in the test groups. Test groups did not differ significantly from each other for all histomorphometric parameters. The implant insertion torque was significantly higher in the control group (P < .0005). The rest of the secondary outcomes were not significantly different between the groups.
CONCLUSION: MSA is a safe and predictable procedure in terms of histological, clinical, and PROAMs, regardless of the biomaterial used. The addition of HA did not influence the outcomes.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  biomaterial(s); bone graft(s); bone regeneration; implantology; osseointegration

Year:  2020        PMID: 33295137     DOI: 10.1111/cid.12964

Source DB:  PubMed          Journal:  Clin Implant Dent Relat Res        ISSN: 1523-0899            Impact factor:   3.932


  5 in total

1.  Characterization of Dental Pulp Stem Cells Response to Bone Substitutes Biomaterials in Dentistry.

Authors:  Rosanna Di Tinco; Ugo Consolo; Alessandra Pisciotta; Giulia Orlandi; Giulia Bertani; Milena Nasi; Jessika Bertacchini; Gianluca Carnevale
Journal:  Polymers (Basel)       Date:  2022-05-30       Impact factor: 4.967

2.  Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate.

Authors:  Eugenio Velasco-Ortega; Angela Sierra-Baztan; Alvaro Jiménez-Guerra; Antonio España-López; Iván Ortiz-Garcia; Enrique Núñez-Márquez; Jesús Moreno-Muñoz; José Luis Rondón-Romero; José López-López; Loreto Monsalve-Guil
Journal:  Int J Environ Res Public Health       Date:  2021-09-22       Impact factor: 3.390

Review 3.  Polymeric Scaffolds for Dental, Oral, and Craniofacial Regenerative Medicine.

Authors:  David T Wu; Jose G Munguia-Lopez; Ye Won Cho; Xiaolu Ma; Vivian Song; Zhiyue Zhu; Simon D Tran
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

4.  Radiographic and Histomorphologic Evaluation of the Maxillary Bone after Crestal Mini Sinus Lift Using Absorbable Collagen-Retrospective Evaluation.

Authors:  Saverio Cosola; Biagio Di Dino; Tonino Traini; Young-Sam Kim; Young-Min Park; Simone Marconcini; Ugo Covani; Raffaele Vinci
Journal:  Dent J (Basel)       Date:  2022-04-02

5.  Evaluation of Quality of Life and Satisfaction in Patients with Fixed Prostheses on Zygomatic Implants Compared with the All-on-Four Concept: A Prospective Randomized Clinical Study.

Authors:  Juan Alberto Fernández-Ruiz; Mariano Sánchez-Siles; Yolanda Guerrero-Sánchez; Jesús Pato-Mourelo; Fabio Camacho-Alonso
Journal:  Int J Environ Res Public Health       Date:  2021-03-25       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.